BioGalen Pharmaceuticals

Sourcing Antimalarials from India: A Buyer's Guide

Buyer's Guide · For importers, distributors & tender suppliers

India is one of the largest global suppliers of quality-assured generic antimalarials, including artemisinin-based combination therapies (ACTs), injectable Artesunate, and Sulfadoxine-Pyrimethamine. For importers, distributors, and tender suppliers, sourcing antimalarials from India means evaluating manufacturer quality certifications, registration dossiers, formulation range, and supply reliability. This guide explains what to check.

Why source antimalarials from India

Indian manufacturers supply a large share of the antimalarials used across Africa and Asia, offering competitive pricing at scale, broad formulation ranges including paediatric dispersible forms, and regulatory documentation suited to registration in importing markets. For high-volume buyers and tender suppliers, India combines manufacturing capacity with cost efficiency.

Check the manufacturer's quality certification

The most important credential is WHO-GMP certification, which indicates the facility meets World Health Organization good manufacturing practice standards. For donor-funded procurement (such as Global Fund or national programmes with international funding), buyers should also check whether the specific product holds WHO Prequalification (WHO-PQ), a stricter standard often required for donor tenders.

Confirm the formulation range you need

Antimalarial procurement often requires specific formulations: standard and dispersible (paediatric) ACT tablets, injectable Artesunate for severe malaria, and Sulfadoxine-Pyrimethamine for seasonal malaria chemoprevention or IPTp. Confirm the manufacturer produces the exact strengths and forms your market requires.

Registration dossiers and your national authority

Importing antimalarials requires product registration with your national regulatory authority (for example, NAFDAC in Nigeria, the Pharmacy and Poisons Board in Kenya, the FDA in Ghana). This requires a regulatory dossier in CTD or ACTD format. A capable manufacturer provides these dossiers and supports the registration process.

Assess supply reliability and terms

For tender and programme supply, reliability matters as much as price. Evaluate the manufacturer's capacity, lead times, minimum order quantities, packaging flexibility, private-label options, and export logistics experience for your market.

How BioGalen supplies antimalarials

BioGalen Pharmaceuticals is a WHO-GMP certified manufacturer and exporter of antimalarials, including Artemether-Lumefantrine (standard and dispersible), Artesunate (tablets and injection), and Sulfadoxine-Pyrimethamine, with CTD and ACTD dossiers and supply to importers, distributors, and tenders across Africa. See our antimalarial range or request a quote.

Frequently Asked Questions

What should I check when sourcing antimalarials from India?
Check the manufacturer's WHO-GMP certification (and WHO Prequalification for donor tenders), confirm they produce the exact formulations you need including paediatric dispersible ACTs and injectable Artesunate, confirm CTD or ACTD registration dossiers are available for your national authority, and assess capacity, lead times, and export experience.
What is the difference between WHO-GMP and WHO Prequalification for antimalarials?
WHO-GMP certification indicates the manufacturing facility meets WHO good manufacturing practice standards. WHO Prequalification (WHO-PQ) is a stricter, product-specific standard often required for donor-funded procurement such as Global Fund tenders.
Do I need to register imported antimalarials with my national authority?
Yes. Importing antimalarials requires registration with your national regulatory authority (such as NAFDAC in Nigeria or the Pharmacy and Poisons Board in Kenya), which requires a CTD or ACTD dossier from the manufacturer.

Sourcing antimalarials from India?

Talk to a WHO-GMP manufacturer about your products, volumes, and target market.